Peter Reichardt - Concepedia

Author

Peter Reichardt

Helios Hospital Berlin-Buch ORCID

Also Known As

P Reichardt, P. Reichardt, P. Reichardt, P. Reichardt, Peter Reichardt, R. Sciot, Reichardt, P., Reichardt, Peter

638

Publications

34.3K

Citations

H-Index

156

Concepts

All Affiliations

Helios Hospital Berlin-Buch Heidelberg University University Hospital Heidelberg Charité - Universitätsmedizin Berlin Helios Hospital Bad Saarow

About

Peter Reichardt is an author at Helios Hospital Berlin-Buch specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	52	125	14.1K
2	Health Sciences	18	33	1.3K
3	Engineering	1	1	26
4	Allergy	1	1	17
5	Biostatistics	1	1	14

Peter Reichardt

222

Publications

28.3K

Citations

H-Index

Page 1

	Year	Citations
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	1.6K
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial George D. Demetri, Peter Reichardt, Yoon‐Koo Kang, The Lancet Gastrointestinal OncologyMedicinePharmacologyPathologyPharmacotherapy	2012	1.4K
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, JAMA	2012	955
Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Leo Kager, A. Zoubek, Ulrike Pötschger, Journal of Clinical Oncology	2003	939
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos, Annals of Oncology Surgical OncologySoft Tissue SurgeryVisceral SarcomasSurgical PathologyHistopathology	2021	879
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	747
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954 Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, Journal of Clinical Oncology	2010	704
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, European Journal of Cancer	2019	700
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. A.S. Lübbe, Christian Bergemann, Hanno Riess, PubMed Magnetic FluidsPharmacotherapyAdvanced Solid TumorsClinical ExperiencesOncology	1996	653
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study Rolf D. Issels, Lars H. Lindner, Jaap Verweij, The Lancet Oncology Surgical OncologyRegional HyperthermiaMalignant DiseaseMedicineRandomised Phase 3	2010	649

Page 1